Ligand Pharma (LGND) Tops Q4 EPS by 63c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Ligand Pharma (LGND) Tops Q4 EPS by 63c, Offers Guidance

Ligand Reports Fourth Quarter and Full Year 2020 Financial Results

February 3, 2021 7:30 AM EST

Raises 2021 Financial Guidance

Conference Call Begins at 8:30 a.m. Eastern Time Today

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2020 and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 8:30 a.m. Eastern time to discuss this announcement and answer questions.

2020 was a stellar year for Ligand, and we are well positioned for an even better 2021. I am... More